nach oben

Journal of Neural Transmission

Erschienen in:

27.09.2018 | Psychiatry and Preclinical Psychiatric Studies - Review Article

Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy

verfasst von: Jean C. Shih

Erschienen in: Journal of Neural Transmission | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Monoamine oxidase (MAO) catalyzes the oxidative deamination of monoamine neurotransmitters and dietary amines. Two pharmacological types with different substrate and inhibitor specificities were reported. Molecular cloning revealed that the two types of MAO were different genes expressed as different proteins with different functions. MAO A and B have identical intron–exon organization derived by duplication of a common ancestral gene thus they are termed isoenzymes. MAO A knockout mice exhibited aggression, the first clear evidence linking genes to behavior. MAO A KO mice exhibited autistic-like behaviors which could be prevented by reducing serotonin levels at an early developmental age (P1–P7) providing potential therapy. MAO B KO mice were non-aggressive and resistant to Parkinsongenic neurotoxin. More recently it was found that MAO A is overexpressed in prostate cancer and correlates with degree of malignancy. The oncogenic mechanism involves a ROS-activated AKT/FOXO1/TWIST1 signaling pathway. Deletion of MAO A reduced prostate cancer stem cells and suppressed invasive adenocarcinoma. MAO A was also overexpressed in classical Hodgkin lymphoma and glioma brain tumors. MAO B was overexpressed in glioma and non-small cell lung cancer. MAO A inhibitors reduce the growth of prostate cancer, drug sensitive and resistant gliomas and classical Hodgkin lymphoma, and enhance standard chemotherapy. Currently, we are developing NIR dye-conjugated clorgyline (MAO A inhibitor) as a novel dual therapeutic/diagnostic agent for cancer. A phase II clinical trial of MAO inhibitor for biochemical recurrent prostate cancer is ongoing. The role of MAO A and B in several cancer types opens new avenues for cancer therapies.

Bach AW, Lan NC, Johnson DL, Abell CW, BEmbenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85:4934–4938CrossRefPubMedPubMedCentral

Bortolato M, Shih JC (2011) Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol 100:13–42CrossRefPubMedPubMedCentral

Bortolato M, Godar SC, Davarian S, Chen K, Shih JC (2009) Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 34:2746–2757CrossRefPubMed

Bortolato M, Godar SC, Alzghoul L, Zhang J, Darling RD, Simpson KL, Bini V, Chen K, Wellman CL, Lin RC, Shih JC (2013a) Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol 16:869–888CrossRefPubMed

Bortolato M, Godar SC, Tambaro S, Devoto P, Chen K, Shih JC (2013b) Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative and anxiety-like behaviors, but not aggression, in MAO A-deficient mice. Neuropharmacology 75:223–232CrossRefPubMed

Bortolato M, Floris G, Shih JC (2018) From aggression to autism: new perspectives on the behavioral sequela of monoamine oxidase deficiency. J Neural Transm (Vienna). https://doi.org/10.1007/s00702-018-1888-y CrossRef

Brunner HG, Nelen M, Breakenfield XO, Ropers HH, van Oost BA (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578–580CrossRefPubMed

Camell CD, Sander J, Spadaro O, Lee A, Nguyen KY, Wing A, Goldberg EL, Youm YH, Brown CW, Elsworth J, Rodeheffer MS, Schultze JL, Dixit VD (2017) Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature 550:119–123PubMedPubMedCentral

Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Poumin S, Muller U, Aquet M, Babinet C, Shih JC (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO A. Science 268:1763–1766CrossRefPubMedPubMedCentral

Chen K, Holschneider DP, Wu W, Rebrin I, Shih JC (2004) A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J Biol Chem 279:39645–39652CrossRefPubMed

Chen K, Ou XM, Wu W, Chen G, Shih JC (2005) R1, a novel repressor of the human monoamine oxidase A. J Biol Chem 25:11552–11559CrossRef

Chen K, Rebrin I, Cases O, Seif I, Shih JC (2007) Forebrain specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure and rescues aggressive behavior in monoamine oxidase A deficient mice. J Biol Chem 282:115–123CrossRefPubMed

Deshwal S, Di Sante M, Di Lisa F, Kaludercic N (2017) Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease. Curr Opin Pharmacol 33:64–69CrossRefPubMed

Godar SC, Bortolato M, Castelli MP, Casti A, Casu A, Chen K, Ennas MG, Tambaro S, Shih JC (2014) The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake. J Psychaitr Res 56:1–9CrossRef

Gordon RR, Wu M, Huang CY, Harris WP, Sim HG, Lucas JM, Coleman I, Higano CS, Gulati R, True LD, Vessella R, Lange PH, Garzotto M, Beer TM, Nelson PS (2014) Chemotherapy induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes. PLoS One 9:e104271CrossRefPubMedPubMedCentral

Grimsby J, Chen K, Wang LJ, lan NC, Shih JC (1991) Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 88:3637–3641CrossRefPubMedPubMedCentral

Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F, Gal J, Shih JC (1997) Increased stress response and β B-deficient mice. Nat Genet 17:206–210CrossRefPubMed

Gross M, Agus D, Dorff T, Pinski J, Quinn D, Shih JC (2016) Invited submission, a late breaking abstract “Interim analysis of phenelzine (a monoamine oxidase inhibitor) for non-metastatic recurrent prostate cancer”, October 30. Presented at Prostate Cancer Foundation Meeting, San Diego

Hare ML (1928) Tyramine oxidase: a new enzyme system in liver. Biochem J 22:968–979CrossRefPubMedPubMedCentral

Hintiryan H, Foster NN, Bowman I, Bay M, Song MY, Gou L, Yamashita S, Bienkowski MS, Zingg B, Zhu M, Yang XW, Shih JC, Toga AW, Dong HW (2016) The mouse cortico-striatal projectome. Nat Neurosci 19:1100–1114CrossRefPubMedPubMedCentral

Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285–1297CrossRefPubMed

Kaludercic N, Mialet-Perez J, Paolocci N, Parini A, Di Lisa F (2014) Monoamine oxidases as sources of oxidants in the heart. J Mol Cell Cardiol 73:34–42CrossRefPubMed

Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393–408PubMed

Kushal S, Wang W, Vaikari VP, Kota R, Chen K, Yeh TS, Jhaveri N, Groshen SL, Olenyuk BZ, Chen TC, Hofman FM, Shih JC (2016) Monoamine oxidase A (MAO A) inhibitors decrease glioma progression. Oncotarget 7:13842–13853CrossRefPubMedPubMedCentral

Lan NC, Chen CH, Shih JC (1989a) Expression of functional human monoamine oxidase A and B cDNAs in mammalian cells. J Neurochem 52:1652–1654CrossRefPubMed

Lan NC, Heinzmann C, Gal A, Klisak I, Orth U, Grimsby J, Sparkes RS, Mohandas T, Shih JC (1989b) Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics 4:552–559CrossRefPubMed

Li PC, Siddiqi IN, Mottok A, Loo EY, Wu CH, Cozen W, Steidl C, Shih JC (2017) Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma. J Pathol 243:220–229CrossRefPubMedPubMedCentral

Liao CP, Lin TP, Li PC, Geary LA, Chen K, Vaikari VP, Wu JB, Lin CH, Gross ME, Shih JC (2018) Loss of MAO A in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate. Oncogene 37:5175–5190CrossRefPubMedPubMedCentral

Lin YC, Chang YT, Campbell M, Lin TP, Pan CC, Lee HC, Shih JC, Chang PC (2017) MAO A-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells. Sci Rep 7:46338CrossRefPubMedPubMedCentral

Ou XM, Chen K, Shih JC (2004) Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine (MAO) B gene. J Biol Chem 279:21021–21028CrossRefPubMed

Ou XM, Chen K, Shih JC (2006a) Glucocorticoid and androgen activation of monoamine oxidase A are regulated by R1 and SP1. J Biol Chem 281:21512–21525CrossRefPubMed

Ou XM, Chen K, Shih J (2006b) Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci USA 103:10923–10928CrossRefPubMedPubMedCentral

Peehl DM, Coram M, Khine H, Reese S, Nolley R, Zhao H (2008) The significance of monoamine oxidase-A expression in high grade prostate cancer. J Urol 180:2206–2211CrossRefPubMedPubMedCentral

Scott AL, Bortolato M, Chen K, Shih JC (2008) Novel monoamine oxidase A knockout mice with human-like spontaneous mutation. Neuroreport 19:739–743CrossRefPubMedPubMedCentral

Sharpe MA, Baskin DS (2016) Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3. Oncotarget 7:3379–3393CrossRefPubMed

Sharpe MA, Livingston AD, Gist TL, Ghosh P, Han J, Baskin DS (2015) Successful treatment of intracranial glioblastoma xenografts with a monoamine oxidase B-activated pro-drug. EBioMedicine 2:1122–1132CrossRefPubMedPubMedCentral

Sharpe MA, Raghavan S, Baskin DS (2018) PAM-OBG: a monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma. Oncotarget 9:23923–23943CrossRefPubMedPubMedCentral

Shih JC (2004) Cloning, after cloning, knock-out mice, and physiological function of MAO A and B. Shih JC NeuroToxicology 25:21–30CrossRefPubMed

Shih JC, Eiduson S (1969) Multiple forms of monoamine oxidase in developing brain. Nature 224:1309–1311CrossRefPubMed

Shih JC, Thompson RF (1999c) Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 65:593–598CrossRefPubMedPubMedCentral

Shih JC, Chen K, Ridd MJ (1999a) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197–217CrossRefPubMedPubMedCentral

Shih JC, Ridd MJ, Chen K, Meehan WP, Kung M-P, Seif I, De Mayer E (1999b) Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A. Brain Res 835:104–112CrossRefPubMed

Shih JC, Wu JB, Chen K (2011) Transcriptional regulation and multiple functions of MAO genes. J Neural Transm 118:979–986CrossRefPubMedPubMedCentral

Singh C, Bortolato M, Balic N, Godard SC, Scott AL, Chen K, Thompson RF, Shih JC (2013) Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. Proc Natl Acad Sci 110:12816–12821CrossRefPubMedPubMedCentral

Son B, Jun SY, Seo H, Youn H, Yang HJ, Kim W, Kim HK, Kang C, Youn B (2016) Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer. Sci Rep 6:21986CrossRefPubMedPubMedCentral

Song MS, Matveychuk D, MacKenzie EM, Duchcherer M, Mousseau DD, Baker GB (2013) An update on amine oxidase inhibitors: multifaceted drugs. Prog Neuropsychopharmacol Biol Psychiatry 44:118–124CrossRefPubMed

True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, Beer TM, Gelmann E, Datta M, Mostaghel E, Knudsen B, Lange P, Vessella R, Lin D, Hood L, Nelson PS (2006) A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci USA 103:10991–10996CrossRefPubMedPubMedCentral

White TA, Kwon EM, Fu R, Lucas JM, Ostrander EA, Stanford JL, Nelson PS (2012) The monoamine oxidase A gene promoter repeat and prostate cancer risk. Prostate 72:1622–7162CrossRefPubMedPubMedCentral

Wong WK, Chen K, Shih JC (2001) Regulation of human monoamine oxidase B gene by Sp1 and Sp3. Mol Pharmacol 59:852–859CrossRefPubMed

Wong WK, Ou X-M, Chen K, Shih JC (2002) Activation of human monoamine oxidase B gene expression by a protein kinase C, MAPK signal transduction pathway involves c-Jun and Egr-1. J Biol Chem 277:22222–22230CrossRefPubMed

Wong WK, Chen K, Shih JC (2003) Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation. J Biol Chem 278:36227–36235CrossRefPubMed

Wu JB, Chen K, Li Y, Lau YF, Shih JC (2009a) Regulation of monoamine oxidase A by the SRY gene on the Y chromosome. FASEB J 23:4029–4038CrossRefPubMedPubMedCentral

Wu JB, Chen K, Ou XM, Shih JC (2009b) Retinoic acid activates monoamine oxidase B promoter in human neuronal cells. J Biol Chem 284:16723–16735CrossRefPubMedPubMedCentral

Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, Li Y, Chen YT, Yin F, Liao CP, Stiles BL, Zhau HE, Shih JC, Chung LW (2014) Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. J Clin Invest 124:2891–2908CrossRefPubMedPubMedCentral

Wu JB, Lin TP, Gallagher JD, Kushal S, Chung LW, Zhau HE, Olenyuk BZ, Shih JC (2015) Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth. J Am Chem Soc 137:2366–2374CrossRefPubMed

Xu S, Adisetiyo H, Tamura S, Grande F, Garofalo A, Roy-Burman P, Neamati N (2015) Dual inhibition of survivin and MAO A synergistically impairs growth of PTEN-negative prostate cancer. Br J Cancer 113:242–251CrossRefPubMedPubMedCentral

Youdim MB, Collins GG, Sandler M (1969) Multiple forms of rat brain monoamine oxidase. Nature 223:626–628CrossRefPubMed

Zhang Z, Chen K, Shih JC, Teng CT (2006) Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Mol Endocr 20:1547–1561CrossRef

Zhu QS, Shih JC (1997) An extensive repeat structure down-regulates human monoamine oxidase A promoter activity independent of an initiator-like sequence. J Neurochem 69:1368–1373CrossRefPubMed

Zhu QS, Grimsby J, Chen K, Shih JC (1992) Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 12:4437–4446CrossRefPubMedPubMedCentral

Zhu QS, Chen K, Shih JC (1994) Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 14:7393–7403CrossRefPubMedPubMedCentral

Ziegler C, Richter J, Mahr M, Gajewska A, Schiele MA, Gehrmann A, Schmidt B, Lesch KP, Lang T, Helbig-Lang S, Pauli P, Kircher T, Reif A, Rief W, Vossbeck-Elsebusch AN, Arolt V, Wittchen HU, Hamm AO, Deckert J, Domschke K (2016) MAO A gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy. Transl Psychiatry 5(6):e773. https://doi.org/10.1038/tp.2016.41 CrossRef

Ziegler C, Wolf C, Schiele MA, Feric Bojic E, Kucukalic S, Sabic Dzananovic E et al (2018) Monoamine oxidase A gene methylation and its role in posttraumatic stress disorder: first evidence from the South Eastern Europe (SEE)-PTSD Study. Int J Neuropsychopharmacol 21:423–432CrossRefPubMed

Titel: Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy
verfasst von: Jean C. Shih
Publikationsdatum: 27.09.2018
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 11/2018
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-018-1927-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2018

Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease

A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths

Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects

Gene–environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions

From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie